Biomarker ID | 1422 |
PMID | 24747338 |
Year | 2014 |
Biomarker | Insulin-Like Growth Factor-Binding Protein 6 (IGFBP-6) |
Biomarker Basis | Concentration Based |
Biomolecule | Protein |
Source | Serum |
Subjects | Humans |
Regulation | Upregulated in PCa: (> 2 fold) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs), Ghrelin-mediated regulation of food intake and energy homeostasis, Diabetes pathways, Myometrial relaxation and contraction pathways, FSH regulation of apoptosis |
Experiment | Prostate Cancer Vs Benign Prostatic Hyperplasia |
Type of Biomarker | Diagnostic |
Cohort | 46 patients with PCa and 42 controls with BPH were selected for analysis |
Senstivity | 97.62% |
Specificity | 67.39% |
AUC | 0.835 |
Accuracy | TP=41; TN=31; FP=15; FN=1 |
Level Of Significance | p<0.0001 |
Method Used | Antibody Microarrays |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |